Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Chiltern wins multiple Pharma Awards at the prestigious annual Pharmatimes Awards Ceremony

January 18, 2011 Research and Development

 
News
Press release

Merck Serono and Domain to co-develop Parkinson’s drugs

January 18, 2011 Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4

Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …
News

Merck suffers late-stage blow to vorapaxar

January 18, 2011 Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar

An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …
News

Merck taps Parexel to help it meet biosimilar ambitions

January 18, 2011 Research and Development Merck & Co, Parexel, biosimilars

Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …
News
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011 Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
News

Gates Foundation funds TB drug discovery

January 14, 2011 Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis

Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …
News

GSK moves Crohn’s disease drug into phase III

January 14, 2011 Research and Development ChemoCentryx, Crohn’s disease, GSK’786, GlaxoSmithKline, Traficet-EN

GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …
News

Anti-cancer stem cell drug starts clinical trials

January 14, 2011 Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers

OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …
News
GSK's UK headquarters

End of the line for GSK’s resveratrol

January 14, 2011 Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol

GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …
News

Watermeadow supports charity cycle ride

January 13, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …
News
Press release
Amgen HQ

Amgen aims for oncology expansion and a wider denosumab license

January 12, 2011 Research and Development AMG- 479, AMG-386, Amgen, Cancer, Pancreatic cancer, denosumab, motasenib

Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …
News

Call to share public health research more openly

January 12, 2011 Research and Development Bill and Melinda Gates Foundation, Wellcome Trust, data sharing, public health

The only way that pressing needs in global public health can be met is for research to be shared more …
News

Lilly and Boehringer sign major diabetes collaboration

January 12, 2011 Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes

Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …
News
spectrum_regulatory_simon_thorn

Dr Simon Thorn joins Spectrum Regulatory Solutions

January 12, 2011 Research and Development Dr Simon Thorn, Specrum Regulatory Services, appointment, research and development

Spectrum Regulatory Solutions has appointed Dr Simon Thorn as a senior regulatory writer. He has more than 15 years experience …
Appointment

Marketing authorisations for medicines: UK Decentralised Procedure slots available in all therapeutic areas in 2011

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The MHRA has reported it has RMS decentralised procedure slots available in 2011 for all therapeutic areas, including biologicals and …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025